NFKB1 and diffuse large B-cell lymphoma: Overexpression of miR-181a significantly decreased the expression and activity of crucial NF-κβ signaling components in DLBCL, leading to reduced tumor cell proliferation and survival by targeting CARD11, NFKB1A, NFKB1, RELA and REL [103].